Human SUMO2/HSMT3/Smt3A ORF/cDNA clone-Lentivirus plasmid (NM_006937)
Cat. No.: pGMLP000323
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human SUMO2/HSMT3/Smt3A Lentiviral expression plasmid for SUMO2 lentivirus packaging, SUMO2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
SUMO2/HSMT3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000323 |
| Gene Name | SUMO2 |
| Accession Number | NM_006937 |
| Gene ID | 6613 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 288 bp |
| Gene Alias | HSMT3,Smt3A,SMT3B,SMT3H2,SUMO3 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCCGACGAAAAGCCCAAGGAAGGAGTCAAGACTGAGAACAACGATCATATTAATTTGAAGGTGGCGGGGCAGGATGGTTCTGTGGTGCAGTTTAAGATTAAGAGGCATACACCACTTAGTAAACTAATGAAAGCCTATTGTGAACGACAGGGATTGTCAATGAGGCAGATCAGATTCCGATTTGACGGGCAACCAATCAATGAAACAGACACACCTGCACAGTTGGAAATGGAGGATGAAGATACAATTGATGTGTTCCAACAGCAGACGGGAGGTGTCTACTGA |
| ORF Protein Sequence | MADEKPKEGVKTENNDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGGVY |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-TA089-Ab | Anti-SUMO2 monoclonal antibody |
| Target Antigen | GM-Tg-g-TA089-Ag | SUMO2 protein |
| ORF Viral Vector | pGMLP000323 | Human SUMO2 Lentivirus plasmid |
| ORF Viral Vector | pGMLV002558 | Human SUMO2 Lentivirus plasmid |
| ORF Viral Vector | pGMPC000058 | Human SUMO2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC001224 | Human SUMO2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC001863 | Human SUMO2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP000323 | Human SUMO2 Lentivirus particle |
| ORF Viral Vector | vGMLV002558 | Human SUMO2 Lentivirus particle |
Target information
| Target ID | GM-TA089 |
| Target Name | SUMO2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
6613 |
| Gene ID |
100630536 (Equus caballus), 101094221 (Felis catus), 132342073 (Bos taurus), 170930 (Mus musculus) 474963 (Canis lupus familiaris), 6613 (Homo sapiens), 690244 (Rattus norvegicus), 705512 (Macaca mulatta) |
| Gene Symbols & Synonyms | SUMO2,Sumo2,Smt3A,Smt3b,SUMO-2,Smt3h2,HSMT3,SMT3B,SUMO3,SMT3H2 |
| Target Alternative Names | HSMT3,SMT3 homolog 2,SMT3B,SMT3H2,SUMO-2,SUMO-3,SUMO2,SUMO3,Sentrin-2,Small ubiquitin-related modifier 2,Smt3A,Smt3b,Smt3h2,Sumo2,Ubiquitin-like protein SMT3B (Smt3B) |
| Uniprot Accession |
P61956,P61957,P61959
Additional SwissProt Accessions: P61957,P61956,P61959 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | |
| Disease from KEGG | Fluid shear stress and atherosclerosis |
| Gene Ensembl | ENSECAG00000030196, ENSBTAG00000030169, ENSMUSG00000020738, ENSCAFG00845027610, ENSG00000188612 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


